Dose-Finding Study of SC411 in Children With Sickle Cell Disease

PHASE2UnknownINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

March 2, 2017

Primary Completion Date

September 26, 2017

Study Completion Date

January 2, 2022

Conditions
Sickle Cell Disease
Interventions
DRUG

Docosahexaenoic Acid

Oral Capsule

DRUG

Placebo

Oral Capsule

Trial Locations (11)

27834

East Carolina University, Greenville

29425

Medical University of South Carolina, Charleston

30322

Children's Healthcare of Atlanta - Emory University, Atlanta

32610

University of Florida Health at Shands, Gainesville

33136

Batchelor Children's Research Institute - University of Miami, Miami

35233

Children's of Alabama - University of Alabama, Birmingham

39216

University of Mississippi Medical Center, Jackson

48201

Children's Hospital of Michigan, Detroit

77030

Texas Children's Hospital - Baylor College of Medicine, Houston

94609

UCSF Benioff Children's Hospital Oakland, Oakland

02115

Boston Children's Hospital, Boston

Sponsors
All Listed Sponsors
lead

Micelle BioPharma Inc

INDUSTRY